Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence

Purpose To describe a cohort with a high risk of recurrence who received bezlotoxumab during the first episode of Clostridioides difficile infection (CDI) and to compare this cohort with patients with similar characteristics who did not receive the monoclonal antibody. Methods A prospective and mult...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of clinical microbiology & infectious diseases 2024-03, Vol.43 (3), p.533-540
Hauptverfasser:	Escudero-Sanchez, Rosa, Ramos-Martínez, Antonio, Caballero-Bermejo, Antonio F., Díaz-Pollán, Beatriz, Ruiz-Carrascoso, Guillermo, Samperio, María Olmedo, García, Patricia Muñoz, Amador, Paloma Merino, Romo, Fernando González, Segarra, Oriol Martín, Jiménez, Gema Navarro, del Campo Albendea, Laura, García, Alfonso Muriel, Cobo, Javier
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Clostridioides difficile Congestive heart failure Creatinine Heart failure Internal Medicine Medical Microbiology Monoclonal antibodies Original Article Patients Risk Vancomycin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!